ABNOM
☆ Dina hasil Stiftung Warentest 2022 ti Jerman, kapuasan konsumen sareng ModelDerm ngan ukur langkung handap tibatan konsultasi telemedicine anu mayar.
References
Laser Q-switched Nd:YAG dipikanyaho sacara efektif ngubaran nevus Ota sareng kaayaan anu sami. Urang ngalaksanakeun hiji ulikan pikeun nempo kumaha ogé hiji high-fluence 1064 nm Q-switched Nd:YAG laser digawé di bintik Mongol di wewengkon mahiwal, tanpa ngabalukarkeun kulit jadi lighten. Urang diajar 61 penderita bintik ieu, examining jumlahna aya 70 lesions. Satengah tina lesi dirawat kalayan laser, sedengkeun anu sanésna ditinggalkeun henteu dirawat pikeun ngabandingkeun. Kami ngevaluasi hasil nganggo skala sareng alat anu disebut Mexameter® pikeun ngukur tingkat melanin. Pasén anu dituturkeun nepi pikeun rata-rata 14 bulan dina grup perlakuan jeung 18 bulan dina grup observasi. Dina ahir pangajaran, urang manggihan béda anu signifikan dina skor skala na tingkat Melanin antara grup dirawat sarta untreated, kalawan grup laser-diperlakukeun némbongkeun hasil hadé. Laser high-fluence Q-switched Nd:YAG , tanpa nyababkeun pencerahan kulit, kabuktian efektif sareng aman pikeun ngubaran bintik Mongol anu teu biasa ieu.
The Q-switched Nd:YAG laser is known to effectively treat nevus of Ota and similar conditions. We conducted a study to see how well a high-fluence 1064 nm Q-switched Nd:YAG laser worked on Mongolian spots in unusual areas, without causing the skin to lighten. We studied 61 patients with these spots, examining a total of 70 lesions. Half of lesions were treated with the laser, while others were left untreated for comparison. We evaluated the results using a scale and a device called a Mexameter® to measure melanin levels. Patients were followed up for an average of 14 months in the treatment group and 18 months in the observation group. At the end of the study, we found significant differences in the scale scores and melanin levels between the treated and untreated groups, with the laser-treated group showing better outcomes. The high-fluence Q-switched Nd:YAG laser, without causing skin lightening, proved effective and safe for treating these unusual Mongolian spots.
The Q-switched Nd:YAG laser is known to effectively treat nevus of Ota and similar conditions. We conducted a study to see how well a high-fluence 1064 nm Q-switched Nd:YAG laser worked on Mongolian spots in unusual areas, without causing the skin to lighten. We studied 61 patients with these spots, examining a total of 70 lesions. Half of lesions were treated with the laser, while others were left untreated for comparison. We evaluated the results using a scale and a device called a Mexameter® to measure melanin levels. Patients were followed up for an average of 14 months in the treatment group and 18 months in the observation group. At the end of the study, we found significant differences in the scale scores and melanin levels between the treated and untreated groups, with the laser-treated group showing better outcomes. The high-fluence Q-switched Nd:YAG laser, without causing skin lightening, proved effective and safe for treating these unusual Mongolian spots.
Urang diajar efektivitas jeung kaamanan ngagunakeun perlakuan laser husus pikeun ABNOM , sarta nempo faktor naon bisa mangaruhan kumaha ogé gawéna. Kami ningali 110 pasien anu ngagaduhan ABNOM sareng ngagaduhan antara dua sareng salapan perlakuan laser. Kami mendakan yén pangobatan langkung saé langkung lami dilakukeun, tapi henteu ogé dina pasien anu langkung lami. Éta ogé dianggo langkung saé pikeun pasién anu gaduh kulit anu langkung hampang (tipe III) sareng daérah anu langkung alit (kirang ti 10 cm2) . Ngagaduhan melasma sareng ABNOM ngajantenkeun pangobatan kirang efektif. Warna atanapi jumlah daérah anu kapangaruhan sigana henteu aya bédana. Sakitar 10% pasien ngagaduhan bintik-bintik poék saatos perawatan. Mimiti sababaraha perlakuan masihan hasil anu saé. Pasién anu langkung kolot sareng kulit anu langkung poék sareng bintik anu langkung poék langkung kamungkinan nampi bintik anu langkung poék saatos dirawat. Pikeun penderita ABNOM sareng melasma, langkung saé ngagunakeun laser énergi anu langkung handap pikeun ngahindarkeun melasma langkung parah.
To evaluate the efficacy and safety of 1064-nm Q-switched Nd:YAG laser (QSNYL) therapy for ABNOM and to identify the factors influencing the outcome. A total of 110 patients with ABNOM were retrospectively evaluated and received two-to-nine treatment sessions. The curative effect was positively correlated with the treatment time and negatively correlated with the increasing age at first treatment (p < 0.05). The curative effect was better in patients with skin type III than those with type IV ( p < 0.05) and in patients with a lesion area of less than 10 cm2 than those with a larger affected area (p < 0.05). Additionally, the treatment effect was poorer in patients with concomitant melasma (p < 0.05). The treatment effect was not significantly correlated with the lesion color or number of affected sites (p > 0.05). Eleven patients (10%) developed postinflammatory hyperpigmentation (PIH). Early and repeated QSNYL therapy achieved satisfactory results for ABNOM. The risk of PIH after laser treatment is highest among patients with older age, darker lesion color, and darker skin color. For patients with ABNOM with concurrent melasma, low-energy laser therapy is recommended to reduce the risk of melasma aggravation.
To evaluate the efficacy and safety of 1064-nm Q-switched Nd:YAG laser (QSNYL) therapy for ABNOM and to identify the factors influencing the outcome. A total of 110 patients with ABNOM were retrospectively evaluated and received two-to-nine treatment sessions. The curative effect was positively correlated with the treatment time and negatively correlated with the increasing age at first treatment (p < 0.05). The curative effect was better in patients with skin type III than those with type IV ( p < 0.05) and in patients with a lesion area of less than 10 cm2 than those with a larger affected area (p < 0.05). Additionally, the treatment effect was poorer in patients with concomitant melasma (p < 0.05). The treatment effect was not significantly correlated with the lesion color or number of affected sites (p > 0.05). Eleven patients (10%) developed postinflammatory hyperpigmentation (PIH). Early and repeated QSNYL therapy achieved satisfactory results for ABNOM. The risk of PIH after laser treatment is highest among patients with older age, darker lesion color, and darker skin color. For patients with ABNOM with concurrent melasma, low-energy laser therapy is recommended to reduce the risk of melasma aggravation.
○ Perlakuan
Agén pemutihan jarang ngabantosan. Beda sareng melasma, ABNOM tiasa dironjatkeun kalayan perawatan laser sareng ditinggalkeun pikeun dipiceun tanpa kambuh deui. Perawatan laser tiasa dilakukeun 10 dugi ka 20 kali pikeun ngubaran ABNOM.
#QS1064 laser